{
    "type": "bundle",
    "id": "bundle--8c1a6fa7-b0c2-4aef-9a35-90476b881023",
    "spec_version": "2.0",
    "objects": [
        {
            "object_marking_refs": [
                "marking-definition--fa42a846-8d90-4e51-bc29-71d5b4802168"
            ],
            "type": "malware",
            "name": "WellMail",
            "x_mitre_aliases": [
                "WellMail"
            ],
            "x_mitre_version": "1.0",
            "modified": "2020-10-09T15:38:41.755Z",
            "created": "2020-09-29T17:48:27.517Z",
            "x_mitre_platforms": [
                "Windows"
            ],
            "id": "malware--959f3b19-2dc8-48d5-8942-c66813a5101a",
            "description": "[WellMail](https://attack.mitre.org/software/S0515) is a lightweight malware written in Golang used by [APT29](https://attack.mitre.org/groups/G0016), similar in design and structure to [WellMess](https://attack.mitre.org/software/S0514).(Citation: CISA WellMail July 2020)(Citation: NCSC APT29 July 2020)",
            "x_mitre_contributors": [
                "Josh Campbell, Cyborg Security, @cyb0rgsecur1ty"
            ],
            "labels": [
                "malware"
            ],
            "created_by_ref": "identity--c78cb6e5-0c4b-4611-8297-d1b8b55e40b5",
            "external_references": [
                {
                    "url": "https://attack.mitre.org/software/S0515",
                    "external_id": "S0515",
                    "source_name": "mitre-attack"
                },
                {
                    "url": "https://us-cert.cisa.gov/ncas/analysis-reports/ar20-198c",
                    "description": "CISA. (2020, July 16). MAR-10296782-3.v1 \u2013 WELLMAIL. Retrieved September 29, 2020.",
                    "source_name": "CISA WellMail July 2020"
                },
                {
                    "url": "https://www.ncsc.gov.uk/files/Advisory-APT29-targets-COVID-19-vaccine-development-V1-1.pdf",
                    "description": "National Cyber Security Centre. (2020, July 16). Advisory: APT29 targets COVID-19 vaccine development. Retrieved September 29, 2020.",
                    "source_name": "NCSC APT29 July 2020"
                }
            ]
        }
    ]
}